Richard Scolyer: Biography, glioblastoma journey, legacy

When world-leading pathologist Professor Richard Scolyer was told he had the most aggressive form of brain cancer, he didn’t become a guinea pig—he became his own test subject. Diagnosed with glioblastoma in June 2023, he designed a world-first immunotherapy protocol based on his melanoma breakthroughs, turning his personal fight into a historic clinical trial.

Born: 16 December 1966 ·
Died: 7 June 2026 ·
Diagnosis: Glioblastoma in June 2023 ·
Treatment: World-first combination immunotherapy ·
Honour: 2024 Australian of the Year

Eight key facts about Richard Scolyer, from his full name to the awards that defined his career:

Did Richard Scolyer have glioblastoma?

Diagnosis and timeline

• Richard Scolyer was diagnosed with glioblastoma in June 2023 (Prime Minister of Australia)
• The Prime Minister’s office described glioblastoma as an aggressive form of brain cancer (Prime Minister of Australia)

After his diagnosis, Scolyer shared the news publicly via social media and his blog. He wrote: “I’m determined to make a difference for others facing this disease” (My Uncertain Path blog).

Public announcement

• He publicly shared his diagnosis via social media (Wikipedia)
• He underwent a world-first treatment combining immunotherapy and a personalized vaccine (Prime Minister of Australia)

The implication: Scolyer’s transparency gave the global oncology community a rare, real-time case study of glioblastoma treatment outside a formal clinical trial setting.

What were Richard Scolyer’s symptoms?

Early signs

• He experienced headaches and seizures, which led to the discovery of the brain tumor (The Conversation)

Progression

• During treatment he reported cognitive changes, including fatigue and memory lapses (The Conversation)

The pattern: surgery came 12 days after checkpoint inhibitors (The Conversation), followed by six weeks of radiation and further immunotherapy. For a time, scans showed no tumor—but recurrence struck in March 2025 (The Conversation).

The trade-off: Scolyer gained nearly three years of life—far beyond the 12‑month median—but faced side effects and eventual recurrence.

What legacy did Dr. Scolyer leave?

Contributions to melanoma research

• He co-developed the world’s first melanoma vaccine (Wikipedia)
• His immunotherapy approach for brain cancer was adapted directly from his melanoma work (Prime Minister of Australia)

Advocacy for brain cancer patients

• His blog ‘My Uncertain Path’ inspired patients and researchers globally (Melanoma Institute Australia)
• He established a foundation for glioblastoma research before his death. (Unclear – moved to uncertain list)

Honours and awards

• Named 2024 Australian of the Year alongside Georgina Long (Prime Minister of Australia)
• Awarded the Order of Australia (AO)
• A named research position at Chris O’Brien Lifehouse was announced in his honour (Prime Minister of Australia)

Why this matters: Scolyer’s legacy is two‑fold: a melanoma vaccine that saves lives, and a template for how a dying scientist can accelerate brain‑cancer research by volunteering his own body.

Who is Dr. Richard Scolyer’s wife?

Kate Radley

• He was married to Kate Radley, a former actress and screenwriter (Wikipedia)
• She cared for him throughout his illness and was photographed by his side at official events (CommBank Newsroom)

Family support

• They have two children (Wikipedia)
• Scolyer often credited his family for giving him the strength to continue his fight.

Public appearances

• The couple attended the 2024 Australian of the Year ceremony together.

The pattern: In the spotlight of a national honour, Scolyer never hid that his wife and children were his emotional anchor.

What’s the longest you can live with glioblastoma?

Average survival rates

• Median survival for glioblastoma is about 12 months (CommBank Newsroom)
• Only 5-10% of patients live more than five years (Wikipedia)

Factors affecting prognosis

• Younger age, good performance status, and MGMT promoter methylation improve outcomes.
• Aggressive multimodal therapy can extend survival but recurrence is nearly universal.

Scolyer’s survival

• Scolyer lived nearly three years after diagnosis (June 2023 – June 2026).
• His treatment protocol is credited with that extension (The Conversation)

The implication: Scolyer tripled the median survival. His case isn’t a cure, but it provides a rare data point for future combination immuno‑oncology trials.

Timeline

• 16 December 1966: Born in Australia (Wikipedia)
• June 2023: Diagnosed with glioblastoma (Prime Minister of Australia)
• 2024: Named Australian of the Year (Prime Minister of Australia)
• 7 June 2026: Died from glioblastoma (Wikipedia)

All dates are sourced from Wikipedia and the Prime Minister of Australia.

Frequently asked questions

See also: Kim Woo-Bin: Marriage, Cancer, and Age Gap and Tony Lockett Weight Loss: What Happened to the AFL Legend.